Author: BEF

A new law that allows patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits went into effect yesterday. The bill, known as the “Improving Access to Clinical Trials Act” (IACT), was signed into law in October 2010. Because of...

A Food and Drug Administration advisory panel said March 8 that genetic tests directly marketed to consumers should be allowed only under a doctor's supervision. Personal testing, which is mainly available online from firms operating outside traditional medical institutions, can produce ambiguous or misleading results without...